Sökning: id:"swepub:oai:DiVA.org:liu-116471" >
Hydrolyzed infant f...
Hydrolyzed infant formula and early β-cell autoimmunity : a randomized clinical trial.
-
- Knip, Mikael (författare)
- University of Helsinki, Helsinki, Finland
-
- Åkerblom, Hans K (författare)
- University of Helsinki, Helsinki, Finland
-
- Becker, Dorothy (författare)
- University of Pittsburgh, Pittsburgh, Pennsylvania, USA
-
visa fler...
-
- Dosch, Hans-Michael (författare)
- University of Toronto, Toronto, Ontario, Canada
-
- Dupre, John (författare)
- University of Western Ontario, London, Canada
-
- Fraser, William (författare)
- University of Montréal, Montréal, Québec, Canada
-
- Howard, Neville (författare)
- Children’s Hospital of Westmead, Sydney, Australia
-
- Ilonen, Jorma (författare)
- University of Turku, Turku, Finland
-
- Krischer, Jeffrey P (författare)
- University of South Florida, Tampa, USA
-
- Kordonouri, Olga (författare)
- Kinder- und Jugendkrankenhaus AUF DER BULT, Hannover, Germany
-
- Lawson, Margaret L (författare)
- Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
-
- Palmer, Jerry P (författare)
- University of Washington, Seattle, USA
-
- Savilahti, Erkki (författare)
- University of Helsinki, Helsinki, Finland
-
- Vaarala, Outi (författare)
- National Institute for Health and Welfare, Helsinki, Finland
-
- Virtanen, Suvi M (författare)
- National Institute for Health and Welfare, Helsinki, Finland
-
visa färre...
-
(creator_code:org_t)
- American Medical Association (AMA), 2014
- 2014
- Engelska.
-
Ingår i: Journal of the American Medical Association (JAMA). - : American Medical Association (AMA). - 0098-7484 .- 1538-3598. ; 311:22, s. 2279-2287
- Relaterad länk:
-
https://jamanetwork....
-
visa fler...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- IMPORTANCE: The disease process leading to clinical type 1 diabetes often starts during the first years of life. Early exposure to complex dietary proteins may increase the risk of β-cell autoimmunity in children at genetic risk for type 1 diabetes. Extensively hydrolyzed formulas do not contain intact proteins.OBJECTIVE: To test the hypothesis that weaning to an extensively hydrolyzed formula decreases the cumulative incidence of diabetes-associated autoantibodies in young children.DESIGN, SETTING, AND PARTICIPANTS: A double-blind randomized clinical trial of 2159 infants with HLA-conferred disease susceptibility and a first-degree relative with type 1 diabetes recruited from May 2002 to January 2007 in 78 study centers in 15 countries; 1078 were randomized to be weaned to the extensively hydrolyzed casein formula and 1081 were randomized to be weaned to a conventional cows' milk-based formula. The participants were observed to April 16, 2013.INTERVENTIONS: The participants received either a casein hydrolysate or a conventional cows' milk formula supplemented with 20% of the casein hydrolysate.MAIN OUTCOMES: AND MEASURES: Primary outcome was positivity for at least 2 diabetes-associated autoantibodies out of 4 analyzed. Autoantibodies to insulin, glutamic acid decarboxylase, and the insulinoma-associated-2 (IA-2) molecule were analyzed using radiobinding assays and islet cell antibodies with immunofluorescence during a median observation period of 7.0 years (mean, 6.3 years).RESULTS: The absolute risk of positivity for 2 or more islet autoantibodies was 13.4% among those randomized to the casein hydrolysate formula (n = 139) vs 11.4% among those randomized to the conventional formula (n = 117). The unadjusted hazard ratio for positivity for 2 or more autoantibodies among those randomized to be weaned to the casein hydrolysate was 1.21 (95% CI, 0.94-1.54), compared with those randomized to the conventional formula, while the hazard ratio adjusted for HLA risk, duration of breastfeeding, vitamin D use, study formula duration and consumption, and region was 1.23 (95% CI, 0.96-1.58). There were no clinically significant differences in the rate of reported adverse events between the 2 groups.CONCLUSIONS AND RELEVANCE: Among infants at risk for type 1 diabetes, the use of a hydrolyzed formula, when compared with a conventional formula, did not reduce the incidence of diabetes-associated autoantibodies after 7 years. These findings do not support a benefit from hydrolyzed formula. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00179777.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Medicinsk genetik (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Medical Genetics (hsv//eng)
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Knip, Mikael
-
Åkerblom, Hans K
-
Becker, Dorothy
-
Dosch, Hans-Mich ...
-
Dupre, John
-
Fraser, William
-
visa fler...
-
Howard, Neville
-
Ilonen, Jorma
-
Krischer, Jeffre ...
-
Kordonouri, Olga
-
Lawson, Margaret ...
-
Palmer, Jerry P
-
Savilahti, Erkki
-
Vaarala, Outi
-
Virtanen, Suvi M
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Medicinsk geneti ...
- Artiklar i publikationen
-
Journal of the A ...
- Av lärosätet
-
Linköpings universitet